Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

US Patent 11617801 · Granted Apr 4, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vendor-agnostic real-time monitoring of telecommunications networks2024
Lightning strike probability-based coordinated power control method for energy s2022
Methods and compositions for treating Leber congenital amaurosis2022
Methods and compositions for treating Leber congenital amaurosis2022
Methods and compositions for treating Leber congenital amaurosis2022
RPGR gene therapy for retinitis pigmentosa2021
Method and system for estimating mass airflow using a mass airflow sensor2021
RP2 and RPGR vectors for treating X-linked retinitis pigmentosa2020
RP2 and RPGR vectors for treating X-linked retinitis pigmentosa2020
RP2 and RPGR vectors for treating X-linked retinitis pigmentosa2020
Methods and compositions for treating leber congenital amaurosis2019
Methods and compositions for treating leber congenital amaurosis2019